| Literature DB >> 35795456 |
Serap Bastepe-Gray1,2, Lavinia Wainwright1, Diane C Lanham1, Gabriela Gomez1, Jieung S Kim1, Zane Forshee2, Bonnie Kaas1, Arita McCoy1, Colin McGregor1, Emile Moukheiber1, Suraj Rajan1, Gerson Suarez-Cedeno1, Jiangxia Wang3, Sean Brennan2, Shane Coughlin2, Kyurim Kang1, Alexander Pantelyat1.
Abstract
Playing musical instruments may have positive effects on motor, emotional, and cognitive deficits in patients with Parkinson's disease (PD). This pilot study examined the feasibility of a six-week nontraditional guitar instruction program for individuals with PD. Twenty-six participants with idiopathic PD (Age: 67.22 ± 8.07; 17 males) were randomly assigned to two groups (intervention first or 6 weeks of usual care control exposure) with stepwise exposure to the guitar intervention condition with cross-over at six weeks. Outcomes were assessed at baseline, 6, 12, and 18 weeks. Twenty-four participants completed the study. Combined analysis of the groups showed significant BDI-II improvement immediately after intervention completion (3.04 points, 95% CI [-5.2, -0.9], p = 0.04). PDQ-39 total quality of life scores improved from baseline to immediately postintervention 5.19 points (95% CI [-9.4, -1.0]) at trend significance (corrected p = 0.07). For Group 1 (exposed to the intervention first), MDS-UPDRS total scores improved by a mean of 8.04 points (95% CI [-12.4, -3.7], p = 0.004) and remained improved at 12 weeks by 10.37 points (95% CI [-14.7, -6.0], p < 0.001). This group also had significant improvements in mood and depression at weeks 6 and 12, remaining significant at week 18 (BDI-II: 3.75, 95% CI [-5.8, -1.7], p = 0.004; NeuroQoL-depression: 10.6, 95% CI [-4.9. -1.4], p = 0.004), and in anxiety at week 6 and week 18 (NeuroQoL; 4.42, 95% CI [-6.8, -2.1], p = 0.004; 3.58, 95% CI [-5.9, -1.2], p = 0.02, respectively). We found clinically and statistically significant improvements in mood/anxiety after 6 weeks of group guitar classes in individuals with PD. Group guitar classes can be a feasible intervention in PD and may improve mood, anxiety, and quality of life.Entities:
Year: 2022 PMID: 35795456 PMCID: PMC9252755 DOI: 10.1155/2022/1061045
Source DB: PubMed Journal: Parkinsons Dis ISSN: 2042-0080
Figure 1A stepped wedge cluster randomized trial consort diagram for participant screening and enrolment.
Figure 2Study design. A closed cohort stepped wedge trial design with two groups (a) and a single cross-over design (b).
Participant characteristics.
| Group 1 (n = 13) | Group 2 (n = 13) |
| ||||
|
| SD |
| SD | |||
|
| ||||||
| Age (years) | 67.78 | 7.57 | 66.67 | 8.81 | 0.72 | |
| Education (years) | 15.12 | 2.35 | 15.81 | 1.18 | 0.36 | |
| MoCA (scores) | 27.46 | 2.18 | 27.08 | 2.90 | 0.66 | |
|
| Percentage (%) |
| Percentage (%) | |||
|
| ||||||
| Sex | Male | 9 | 69.23 | 8 | 61.54 | 1.00 |
| Female | 4 | 30.77 | 5 | 38.46 | ||
|
| ||||||
| Hoehn and yahr | 2 | 10 | 76.92 | 13 | 100 | 0.22 |
| 2.5 | 1 | 7.69 | 0 | 0 | ||
| 3 | 0 | 0 | 0 | 0 | ||
| 4 | 2 | 15.38 | 0 | 0 | ||
|
| ||||||
| Race | White | 13 | 100 | 12 | 92.31 | 1.00 |
| African-American | 0 | 0 | 1 | 7.69 | ||
|
| ||||||
| Handedness | Right | 13 | 100 | 10 | 76.92 | 0.22 |
| Left | 0 | 0 | 3 | 23.08 | ||
Outcome measurements at the beginning of the trial (week 0) and at pre-intervention baseline (Xb).
| Motor and emotion outcomes, mean (SD) | Trial start (week 0) | Preintervention baseline ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Group1 ( | Group 2 ( | Uncorrected | Corrected | Group1 ( | Group 2 Week 6 visit ( | Uncorrected | Corrected | |
| MDS-UPDRS motor total | 38.8 (13.6) | 36.8 (14.3) | 0.71 | 0.80 | 38.8 (13.6) | 23.8 (13.8) | 0.01∗∗ | 0.05 |
| Typing test accuracy, dominant hand | 137.0 (78.3) | 114.4 (53.2) | 0.40 | 0.53 | 137.0 (78.3) | 111.7 (46.4) | 0.33 | 0.47 |
| Typing test accuracy, non-dominant hand | 110.6 (49.2) | 106.5 (42.6) | 0.82 | 0.85 | 110.6 (49.2) | 106.6 (42.2) | 0.83 | 0.85 |
| PDQ39 total score | 43.2 (20.4) | 31.8 (23.0) | 0.19 | 0.32 | 43.2 (20.4) | 30.2 (19.7) | 0.11 | 0.22 |
| Beck depression inventory total score | 14.8 (6.3) | 10.1 (6.2) | 0.07 | 0.16 | 14.8 (6.3) | 9.9 (7.3) | 0.08 | 0.17 |
| Apathy evaluation scale total score | 51.3 (6.6) | 55.2 (10.0) | 0.26 | 0.40 | 51.3 (6.6) | 53.7 (11.8) | 0.05 | 0.13 |
| NeuroQoL depression raw score | 13.8 (4.2) | 11.2 (2.9) | 0.08 | 0.17 | 13.8 (4.2) | 12.5 (6.0) | 0.50 | 0.64 |
| NeuroQoL anxiety raw score | 17.2 (5.0) | 15.4 (4.4) | 0.35 | 0.50 | 17.2 (5.0) | 15.6 (6.7) | 0.52 | 0.64 |
a p values are adjusted for multiple comparisons using the Simes method. ∗p < 0.05. ∗∗p < 0.01.
Combined group analysis-effect of intervention immediately after and 6 weeks after completion of the intervention (n = 26).
| Outcomes | Changes from preintervention (Xb) to immediately postintervention (Xpi) | Changes from preintervention (Xb) to 6 weeks after completion of intervention | ||||||
|---|---|---|---|---|---|---|---|---|
| Coefficient | 95% CI | Uncorrected | Corrected | Coefficient | 95% CI | Uncorrected | Corrected | |
| MDS-UPDRS motor total | −1.76 | −5.4, 1.9 | 0.34 | 0.50 | −3.80 | −7.4, −0.2 | 0.04∗ | 0.12 |
| Typing test accuracy with dominant hand | 7.19 | −5.6, 20.0 | 0.27 | 0.41 | 11.36 | −1.4, 24.1 | 0.08 | 0.17 |
| Typing test accuracy with nondominant hand | −0.43 | −10.6, 9.8 | 0.93 | 0.95 | 10.16 | 0.0, 20.3 | 0.05 | 0.13 |
| PDQ-39 total score | −5.19 | −9.4, −1.0 | 0.02∗ | 0.07 | −3.48 | −7.7, 0.7 | 0.10 | 0.21 |
| Beck depression Inventory-II total score | −3.04 | −5.2, −0.9 | 0.006∗∗ | 0.04 | −2.16 | −4.3, 0.0 | 0.05 | 0.13 |
| Apathy evaluation scale total score | 1.74 | 0.1, 3.4 | 0.04∗ | 0.12 | 2.36 | 0.7, 4.0 | 0.005∗∗ | 0.03∗ |
| NeuroQoL depression raw score | −1.65 | −2.9, −0.4 | 0.01∗ | 0.05 | −1.27 | −2.5, 0.0 | 0.049∗ | 0.13 |
| NeuroQoL anxiety raw score | −1.83 | −3.6, −0.1 | 0.04∗ | 0.12 | −0.41 | −2.2, 1.4 | 0.65 | 0.77 |
a p values are adjusted for multiple comparisons using the Simes method. ∗p < 0.05. ∗∗p < 0.01.
Figure 3Combined and stratified analysis by intervention group-effect of intervention immediately after intervention (Xpi), 6 weeks postintervention (X6wpi) and 12 weeks postintervention (X12wpi; Group 1 only).
Stratified analysis by intervention groups-effect of intervention immediately after intervention (Xpi), 6 weeks postintervention (X6wpi), and 12 weeks postintervention (X12wpi; Group 1 only).
| Outcomes | Time point | Early intervention exposure group-Group 1 ( | Delayed intervention exposure group-Group 2 ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Coefficient | 95% CI | Uncorrected | Corrected | Mean (SD) | Coefficient | 95% CI | Uncorrected | Corrected | ||
| MDS-UPDRS motor total | Postintervention (Xpi) | 29.8 (11.3) | −8.04 | −12.4, −3.7 | <0.001∗∗∗ | 0.004∗∗ | 27.4 (15.0) | 5.06 | 0.74, 9.38 | 0.02 | 0.09 |
| X6wpi | 27.5 (16.2) | −10.37 | −14.7, −6.0 | <0.001∗∗∗ | <0.001∗∗ | 25.7 (11.0) | 3.31 | −1.01, 7.63 | 0.13 | 0.24 | |
| X12wpi | 33.8 (12.5) | −4.04 | −8.4, 0.3 | 0.07 | 0.16 | ||||||
|
| |||||||||||
| Typing accuracy, dominant hand | Postintervention (Xpi) | 144.8 (72.1) | 3.05 | −14.2, 20.3 | 0.73 | 0.80 | 123.8 (54.0) | 10.97 | −4.30, 26.25 | 0.16 | 0.29 |
| X6wpi | 151.8 (74.4) | 10.05 | −7.2, 27.3 | 0.25 | 0.40 | 125.1 (64.9) | 12.31 | −2.97, 27.58 | 0.11 | 0.22 | |
| X12wpi | 144.4 (78.3) | 2.63 | −14.6, 19.8 | 0.76 | 0.82 | ||||||
|
| |||||||||||
| Typing accuracy, nondominant hand | Postintervention (Xpi) | 115.0 (53.8) | 2.11 | −12.94, 17.15 | 0.78 | 0.83 | 106.6 (42.2) | −1.93 | −12.78, 8.92 | 0.73 | 0.80 |
| X6wpi | 131.8 (63.7) | 18.86 | 3.8, 33.9 | 0.01 | 0.06 | 111.0 (51.5) | 2.49 | −8.36, 13.34 | 0.65 | 0.77 | |
| X12wpi | 121.6 (49.4) | 8.69 | −6.35, 23.83 | 0.26 | 0.40 | ||||||
|
| |||||||||||
| PDQ-39 total score | Postintervention (Xpi) | 34.7 (14.7) | −6.21 | −12.0, −0.5 | 0.03 | 0.12 | 24.2 (18.4) | −3.72 | −9.35, 1.90 | 0.19 | 0.32 |
| X6wpi | 36.3 (14.7) | −4.63 | −10.4, 1.1 | 0.12 | 0.22 | 26.0 (21.4) | −1.89 | −7.51, 3.73 | 0.51 | 0.64 | |
| X12wpi | 34.7 (18.1) | −6.17 | −11.9, −0.4 | 0.04 | 0.12 | ||||||
|
| |||||||||||
| Beck depression inventory–II total score | Postintervention (Xpi) | 9.2 (6.6) | −4.50 | −6.6, −2.4 | <0.001∗∗∗ | 0.001∗∗ | 8.8 (5.3) | −1.08 | −4.13, 1.97 | 0.49 | 0.63 |
| X6wpi | 9.8 (3.0) | −3.83 | −5.9, −1.7 | <0.001∗∗∗ | 0.004∗∗ | 9.8 (7.6) | 0.01 | −3.04, 3.06 | 0.10 | 0.10 | |
| X12wpi | 9.9 (5.1) | −3.75 | −5.8, −1.7 | <0.001∗∗∗ | 0.004∗∗ | ||||||
|
| |||||||||||
| Apathy evaluation scale total score | Postintervention (Xpi) | 52.7 (6.1) | 0.98 | −1.3, 3.3 | 0.40 | 0.53 | 56.8 (8.4) | 2.53 | 0.63, 4.43 | 0.009∗∗ | 0.05 |
| X6wpi | 54.3 (4.6) | 2.65 | 0.3, 5.0 | 0.03 | 0.10 | 56.3 (9.9) | 2.12 | 0.22, 4.02 | 0.029 | 0.11 | |
| X12wpi | 53.3 (5.0) | 1.57 | −0.7, 3.9 | 0.18 | 0.32 | ||||||
|
| |||||||||||
| NeuroQoL depression raw score | Postintervention (Xpi) | 11.1 (2.5) | −2.64 | −4.4, −0.9 | 0.003 | 0.02 | 11.3 (4.2) | −0.90 | −2.71, 0.91 | 0.33 | 0.47 |
| X6wpi | 10.4 (1.9) | −3.31 | −5.0, −1.6 | <0.001∗∗∗ | 0.004∗∗ | 12.8 (6.1) | 0.52 | −1.29, 2.33 | 0.58 | 0.70 | |
| X12wpi | 10.6 (1.9) | −3.14 | −4.9, −1.4 | <0.001∗∗∗ | 0.004∗∗ | ||||||
|
| |||||||||||
| NeuroQoL anxiety raw score | Postintervention (Xpi) | 12.3 (2.5) | −4.42 | −6.8, −2.1 | <0.001∗∗∗ | 0.004∗∗ | 16.1 (6.0) | 0.40 | −1.89, 2.68 | 0.74 | 0.80 |
| X6wpi | 14.4 (3.7) | −2.33 | −4.7, 0.0 | 0.05 | 0.13 | 16.8 (7.6) | 1.15 | −1.14, 3.43 | 0.33 | 0.50 | |
| X12wpi | 13.2 (4.1) | −3.58 | −5.9, −1.2 | 0.003∗∗ | 0.02 | ||||||
1 p values are adjusted for multiple comparisons using the Simes method. ∗p < 0.05. ∗∗p < 0.01. ∗∗∗p < 0.001.